Suppression of telomerase activity in HL60 cells after treatment with differentiating agents

Leukemia

Volumn 10, Issue 8, 1996, Pages 1354-1357

  Xu, D ^a   Gruber, A ^a   Peterson, C ^a   Pisa, P ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Differentiation; HL60 cell line; Telomerase activity; Telomerase regulation

Indexed keywords

CALCITRIOL; CD11B ANTIGEN; CELL ENZYME; RETINOIC ACID; TELOMERASE;

ARTICLE; CELL DIFFERENTIATION; CELL STRAIN HL 60; CELL STRAIN K 562; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ERYTHROLEUKEMIA CELL; GRANULOCYTE; HUMAN; HUMAN CELL; MONOCYTE; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; CELL LINE; CELL SURVIVAL; CYTOLOGY; DRUG ANTAGONISM; ENZYMOLOGY; ERYTHROLEUKEMIA; KINETICS; TIME;

CALCITRIOL; CELL DIFFERENTIATION; CELL LINE; CELL SURVIVAL; GRANULOCYTES; HL-60 CELLS; HUMANS; KINETICS; LEUKEMIA, ERYTHROBLASTIC, ACUTE; MACROPHAGE-1 ANTIGEN; MONOCYTES; TELOMERASE; TIME FACTORS; TRETINOIN;

EID: 0029666139     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Harley CB, Kim NW, Prowse KR, Weinreich SL, Hirsch KS, West MD, Bacchetti S, Hirte HW, Counter CM, Greider CW, Piatyszek MA, Weight WE, Shay JW. Telomerase, cell immortality, and cancer. In: Cold Spring Harbour Symposia on Quantitative Biology LIX. Cold Spring Harbor Lab Press: Cold Spring Harbor, NY, 1994, pp 307-315.
2. Harley CB, Futcher AB, Greider CW. Telomeres shorten during ageing of human fibroblasts. Nature 1990; 345: 458-460.
3. Hastie ND, Dempster M, Dunlop MC, Thompson AM, Green DK, Allshire RC. Telomere reduction in human colorectal cancer and with ageing. Nature 1990; 346: 866-868.
4. Allsopp RC, Vaziri H, Patterson C, Goldstein S, Younglai EV, Futcher AB, Greider CW. Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci USA 1992; 89: 10114-10118.
5. Prowse KR, Greider CW. Developmental and tissue-specific regulation of mouse telomerase and telomere length. Proc Natl Acad Sci USA 1995; 92: 4818-4822.
6. Feng L, Funk WD, Wang S-S, Weinrich SL, Avillion AA, Chiu CD, Adams RR, Chang E, Allsopp RC, Yu J, Le S, West MD, Harley CB, Andrews WH, Greider CW, Villeponteau B. The RNA component of human telomerase. Science 1995; 269: 1236-1241.
7. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PLC, Coviello GM, Wright WE, Weinrich SL, Shay JW. Specific association of human telomerase activity with immortal cells and cancer. Science 1994; 266: 2011-2015.
8. Counter CM, Hirte HW, Bacchetti S, Harley CB. Telomerase activity in human ovarian carcinoma. Proc Natl Acad Sci USA 1994; 91: 2900-2904.
9. Hiyama E, Hiyama K, Yokoyama T, Matsaura Y, Piatyszek MA, Shay JW. Correlating telomerase activity levels with human neuroblastoma outcomes. Nature Med 1995; 1: 249-257.
10. Chadeneau C, Hay K, Gallinger S, Bacchetti S. Telomerase activity associated with acquisition of malignancy in human colorectal cancer. Cancer Res 1995; 55: 2533-2536.
11. Tahara H, Nakanishi T, Kitamoto M, Nakashio R, Shay J, Tahara E, Kajiyama G, Ide T. Telomerase activity in human liver tissues: comparison between chronic liver disease and hepatocellular carcinomas. Cancer Res 1995; 55: 2734-2736.
12. Hiyama E, Yokoyama T, Tatsumoto N, Hiyama K, Imamura Y, Murakami Y, Kodama T, Piatyszek MA, Shay JW, Matsuura Y. Telomerase activity in gastric cancer. Cancer Res 1995; 55: 3258-3262.
13. Hiyama K, Hiyama E, Ishioka S, Yamakido M, Inai K, Gazdar AF, Piatyszek MA, Shay JW. Telomerase activity in small-cell and non-small-cell lung cancers. J Natl Cancer Inst 1995; 87: 895-902.
14. Tahara H, Kuniyasu H, Yokozaki H, Yasui W, Shay JW, Ide T, Tahara E. Telomerase activity in preneoplastic and neoplastic gastric and colorectal lesions. Clin Cancer Res 1995; 1: 1245-1251.
15. Xu D, Palucka AK, Peterson C, Björkholm M, Gruber A, Pisa P. Telomerase is expressed in normal human hematopoietic cells from umbilical cord blood, adult peripheral blood and bone marrow. Blood 1995; 86: 685a.
16. Chiu CP, Dragowski V, Kim NW, Thomas TE, Harley CB, Lansdorp PM. Telomerase activity in hematopoietic progenitor cells extracts from adult bone marrow. Proc Am Assoc Cancer Res 1995; 36: 555.
17. Hiyama K, Hirai Y, Kyoizumi S, Akiyama M, Hiyama E, Piatyszek MA, Shay JW, Ishioko S, Yamakido M. Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J Immunol 1995; 155: 3711-3715.
18. Sachs L. Constitutive uncoupling of pathways of gene expression that control growth and differentiation in myeloid leukemia: a model for the origin and progression of malignancy. Proc Natl Acad Sci USA 1980; 77: 6152-6156.
19. Atkins KB, Troen BR. Comparative responsiveness of HL-60, HL-60R, and HL-60R+ (LRARSN) cells to retinoic acid, calcitriol, 9 cis-retinoic acid, and sodium butyrate. Blood 1995; 86: 2475-2480.
20. 3 results in differentiation towards neutrophils or monocytes or a failure to differentiate and apoptosis. Leukemia 1995; 9: 410-418.
21. Olsson I, Gullberg U, Ivhed I, Nilsson K. Induction of differentiation of the human histiocytic lymphoma cell line U-937 by 1α, 25-dihydroxycholecalciferol. Cancer Res 1983; 43: 5862-5867.
22. Breitman TR, Selonick SE, Collins SJ. Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid. Proc Natl Acad Sci USA 1980; 52: 2936-2940.
23. Chomienne C. Low-dose chemotherapy and differentiating agents. Clin Hematol 1991; 4: 47-68.
24. Bollag W, Majewski S, Jablonska S. Cancer combination chemotherapy with retinoids: experimental rationale. Leukemia 1994; 8: S11-S15.
25. Nilsson B. Probable induction of differentiation in vivo by retinoic acid of promyelocytes in acute promyelocytic leukemia. Br J Haematol 1984; 57: 365-371.
26. 3: in vivo and in vitro effects on human preleukemic and leukemic cells. Cancer Treat Rep 1985; 69: 1399-1407.
27. 3 and retinoic acid in acute leukemia and myelodysplastic syndromes. Eur J Haematol 1988; 40: 449-459.
28. Huang M, Yu-Chen Y, Shu-Rong C, Lu MX, Zhoa L, Gu LJ, Wang ZY. Use of all-trans retinoic acid in promyelocytic leukemia. Blood 1988; 72: 567-572.
29. Degos L, Dombret H, Chomienne C, Daniel M-T, Micléa J-M, Chastang C, Castaigne S, Fenaux P. All-trans retinoic acid as a differentiating agent in the treatment of acute promyelocytic leukemia. Blood 1995; 85: 2643-2653.